Hologic Inc. | Income Statement

Fiscal year is October-September. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,492
2,531
2,705
2,833
3,059
3,218
Cost of Goods Sold (COGS) incl. D&A
1,442
1,372
1,383
1,359
1,500
1,581
Gross Income
1,051
1,159
1,323
1,474
1,559
1,637
SG&A Expense
767
794
839
915
1,068
1,129
EBIT
283
365
484
559
503
508
Unusual Expense
1,259
100
91
17
39
785
Non Operating Income/Expense
63
2
11
28
916
1
Interest Expense
281
221
206
155
153
149
Pretax Income
1,193
48
177
415
1,231
419
Income Tax
20
31
46
85
475
307
Consolidated Net Income
1,173
17
132
331
756
111
Net Income
1,173
17
132
331
756
111
Net Income After Extraordinaries
1,173
17
132
331
756
111
Net Income Available to Common
1,173
17
132
331
756
111
EPS (Basic)
4.36
0.06
0.45
1.16
2.64
0.40
Basic Shares Outstanding
269
275
281
280
280
275
EPS (Diluted)
4.36
0.06
0.45
1.16
2.64
0.40
Diluted Shares Outstanding
269
278
290
286
286
275
EBITDA
799
888
975
1,025
952
988
Other Operating Expense
-
-
-
-
12
-
Non-Operating Interest Income
1
1
1
1
4
6

About Hologic

View Profile
Address
250 Campus Drive
Marlborough Massachusetts 01752
United States
Employees -
Website http://www.hologic.com
Updated 07/08/2019
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems.